Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
16
pubmed:dateCreated
2009-8-14
pubmed:abstractText
To investigate the clinical relevance of the recently characterized human oncoprotein cancerous inhibitor of protein phosphatase 2A (CIP2A) in human breast cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5092-100
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:19671842-Adult, pubmed-meshheading:19671842-Aged, pubmed-meshheading:19671842-Aged, 80 and over, pubmed-meshheading:19671842-Animals, pubmed-meshheading:19671842-Autoantigens, pubmed-meshheading:19671842-Breast Neoplasms, pubmed-meshheading:19671842-Carcinoma, pubmed-meshheading:19671842-Cell Proliferation, pubmed-meshheading:19671842-Female, pubmed-meshheading:19671842-Gene Expression Regulation, Neoplastic, pubmed-meshheading:19671842-Genetic Linkage, pubmed-meshheading:19671842-Humans, pubmed-meshheading:19671842-Membrane Proteins, pubmed-meshheading:19671842-Mice, pubmed-meshheading:19671842-Middle Aged, pubmed-meshheading:19671842-Neoplasm Invasiveness, pubmed-meshheading:19671842-Neoplasm Metastasis, pubmed-meshheading:19671842-RNA, Small Interfering, pubmed-meshheading:19671842-Tumor Cells, Cultured, pubmed-meshheading:19671842-Xenograft Model Antitumor Assays
pubmed:year
2009
pubmed:articleTitle
CIP2A is associated with human breast cancer aggressivity.
pubmed:affiliation
Centre for Biotechnology, University of Turku, Turku, Finland.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Validation Studies